Tellgen Corporation
300642
Rang in Aktien
#13946
Tellgen Corporation is dedicated to the creation, manufacturing, and supply of... Tellgen Corporation is dedicated to the creation, manufacturing, and supply of in-vitro diagnostic (IVD) solutions, serving both the Chinese domestic market and a global clientele. Their extensive product catalog includes cancer detection markers, test kits for human papilloma virus (HPV), ToRCH diagnostic assays, Y-chromosome microdeletion screening kits, and sophisticated multiplex immunoassay systems. The company, founded in 2003, operates from its headquarters in Shanghai, China.
Aktienkurs
$2.59
Marktkapitalisierung
$420.62M
Veränderung (1 Tag)
-9.56%
Veränderung (1 Jahr)
-28.57%
Land
CN
Handel Tellgen Corporation (300642)
Kategorie
Healthcare
Kursverlauf für Tellgen Corporation (300642)
Höchster Schlusskurs: $2.80 am 2026-10-01
Niedrigster Schlusskurs: $3.59 am 2017-04-01
Niedrigster Schlusskurs: $3.59 am 2017-04-01
Kursverlauf der Aktie von Tellgen Corporation von 2017 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | -7.04% |
| 2025 | 24.20% |
| 2024 | -14.78% |
| 2023 | -20.19% |
| 2022 | -35.03% |
| 2021 | 2.84% |
| 2020 | 47.58% |
| 2019 | -6.06% |
| 2018 | -34.45% |
| 2017 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $102.28 | -20.07% |
US
|
|
| $95.91 | 0.01% |
IE
|
|
| $305.79 | -21.26% |
US
|
|
| $45.76 | -55.94% |
US
|
|
| $47.05 | -17.88% |
DE
|
